Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN – Get Free Report) was the recipient of a large growth in short interest in the month of February. As of February 13th, there was short interest totaling 637,842 shares, a growth of 146.4% from the January 29th total of 258,858 shares. Based on an average trading volume of 2,622,397 shares, the short-interest ratio is currently 0.2 days. Approximately 5.1% of the shares of the stock are short sold. Approximately 5.1% of the shares of the stock are short sold. Based on an average trading volume of 2,622,397 shares, the short-interest ratio is currently 0.2 days.
Inspira Technologies OXY B.H.N. Trading Down 1.6%
Shares of IINN traded down $0.01 during mid-day trading on Friday, hitting $0.58. 92,026 shares of the company were exchanged, compared to its average volume of 1,450,022. Inspira Technologies OXY B.H.N. has a 1-year low of $0.40 and a 1-year high of $1.65. The company has a quick ratio of 0.90, a current ratio of 1.15 and a debt-to-equity ratio of 0.27. The company has a 50 day moving average of $0.79 and a 200-day moving average of $1.00.
Hedge Funds Weigh In On Inspira Technologies OXY B.H.N.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Kestra Advisory Services LLC acquired a new stake in shares of Inspira Technologies OXY B.H.N. in the fourth quarter worth approximately $71,000. Citadel Advisors LLC acquired a new position in Inspira Technologies OXY B.H.N. in the 3rd quarter valued at $105,000. Finally, Yorkville Advisors Global LP purchased a new position in Inspira Technologies OXY B.H.N. in the 4th quarter valued at $1,605,000. Hedge funds and other institutional investors own 12.72% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on IINN
Inspira Technologies OXY B.H.N. Company Profile
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.
Featured Stories
- Five stocks we like better than Inspira Technologies OXY B.H.N.
- 3 Signs You May Want to Switch Financial Advisors
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Inspira Technologies OXY B.H.N. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspira Technologies OXY B.H.N. and related companies with MarketBeat.com's FREE daily email newsletter.
